Bronstein, Gewirtz & Grossman, LLC has launched a legal investigation into Hims & Hers Health's corporate practices. The probe focuses on potential wrongdoing by certain officers and directors ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

Hims & Hers continues growing rapidly, but shrinking margins and rising costs are beginning to test the company's long-term profitability story.

March 9 (Reuters) - Hims & Hers' shares were up ⁠over ⁠40% on Monday, after ⁠Novo Nordisk agreed to sell its blockbuster Wegovy and Ozempic drugs through the telehealth firm's platform, signaling an ...

Hims & Hers (HIMS) has caught a powerful new tailwind, and the market is treating peptides as more than a short-lived headline. The immediate catalyst was the FDA’s decision to hold a July 23-24 ...

Hims is expanding beyond telehealth with a push into hormone care, while building out at-home testing and virtual care services. ・Peptides is also seen as the next growth driver, with Bank of America ...

Hims is a telehealth company offering discreet virtual consultations and prescription delivery for men's health concerns. Hims' hair loss program uses FDA-approved treatments like finasteride and ...

Learn more Hims & Hers Health (NYSE:HIMS), a consumer-focused telehealth platform offering prescription and non-prescription ...

Feb 7 (Reuters) - Online telehealth company Hims & Hers ‌on Saturday reversed course on its launch of a $49 ‌compounded version of Novo Nordisk's Wegovy weight-loss pill after the U.S. Food and Drug ...

Hims & Hers Health (HIMS +3.34%), the consumer-focused telehealth platform, closed Tuesday at $29.76, down 4.03%. The stock declined during the regular session after Amazon (AMZN 1.19%) launched a ...

Shares of Hims & Hers Health Inc. climbed sharply in morning trading Friday as investors bet that potential regulatory relief on compounded peptides could strengthen the telehealth company's ...